We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen’s Subpoena Of Reporter In Aranesp Securities Case Quashed By Court

(September 2, 2015, 12:03 PM EDT) -- WASHINGTON, D.C. — A District of Columbia federal judge on Aug. 21 granted a reporter’s motion to quash a subpoena seeking to depose him in a securities class action, finding that the issuing firm failed to overcome the reporter’s privilege under the First Amendment to the U.S. Constitution (Paul B. Goldberg v. Amgen Inc., No. 1:15-mc-00825, D. D.C.; 2015 U.S. Dist. LEXIS 110726).

(Memorandum opinion and order available. Document #68-150910-006Z.)

Shareholder Action

Biotechnology firm Amgen Inc. is presently involved in a shareholder class action in the...
To view the full article, register now.